Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers

Background: Most of the patients with Pancreatic Ductal Adenocarcinoma (PDA) are not eligible for a curative surgical resection. For this reason there is an urgent need for personalized therapies. PDA is the result of complex interactions between tumor molecular profile and metabolites produced by i...

Full description

Saved in:
Bibliographic Details
Published in:Front Oncol
Main Authors: Follia, Laura, Ferrero, Giulio, Mandili, Giorgia, Beccuti, Marco, Giordano, Daniele, Spadi, Rosella, Satolli, Maria Antonietta, Evangelista, Andrea, Katayama, Hiroyuki, Hong, Wang, Momin, Amin A., Capello, Michela, Hanash, Samir M., Novelli, Francesco, Cordero, Francesca
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2019
Subjects:
Oncology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6400843/
https://ncbi.nlm.nih.gov/pubmed/30873387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00115
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items